Attached files
file | filename |
---|---|
EX-10.1 - DISMISSAL LETTER OF BFBORGERS, CPA, PC - GENETHERA INC | exhibit_10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
Date of Report (Date of earliest event reported) March 9,
2020
GENETHERA, INC.
(Exact
name of Registrant as specified in its charter)
NEVADA
|
|
000-27237
|
|
65-0622463
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
|
|
3051 W. 105th
Ave.# 350251
Westminster, CO
|
|
|
|
80035
|
(Address of principal executive offices)
|
|
|
|
(Zip Code)
|
Registrant's telephone number, including area code (303)
955-0190
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
1
On March 9, 2019, GeneThera, Inc. terminated its engagement
relationship with BFBorgers, CPA, PC; its former independent
auditors. There were no disagreements or disputed matters between
the Company and Ben Borges on any matter of accounting principles
or practices, financial statement disclosures, or any matters
concerning, and/or related to auditing scope or
procedure.
On March 9, 2019 the Board of Directors voted to formally engage
MaughanSullivan, LLC as the Company’s new independent
auditors for the year ended December 31, 2019; including all
quarterly reviews and audits, thereafter.
ITEM 9.01 EXHIBITS
Exhibit Number
|
|
Description
|
|
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
March
9, 2020
|
GENETHERA,
INC.
|
|
|
|
|
|
By:
|
/s/
Tannya L. Irizarry
|
|
|
Tannya
L. Irizarry
Chief
Financial Officer
|
2